Atlas Trials

Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure

Clinical trial NCT01394562 · COMPLETED

Trial details

NCT number
NCT01394562
Sponsor
Vifor Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Iron DeficiencyChronic Heart Failure
Start date
2011-07-01
Primary completion
2016-05-01
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.